A convenient synthetic route for preparation of various 4-[4-(1H-indol-3-yl)butyl]piperazines bearing heterocyclic and aliphatic substituents in position 1 has been developed. During this work some synthetic possibilities of common precursor, 4-[4-(1H-indol-3-yl)butyl]piperazine, were studied and evaluated.
Introduction

4-[4-(1H-
and 5-hydroxytryptamine 5-HT 1D agonists. 3, 4 We have synthesized a series of 1-substituted 4-[4-(1H-indol-3-yl)butyl]piperazines and hydroxamic acid derivatives, containing 1-substituted 4-[4-(1H-indol-3-yl)butyl]piperazine scaffold. Known methods for the synthesis of compounds of this type are based on the reaction of (1H-indol-3-yl)alkyl methanesulfonate, 5, 6 iodide 7 or chloride 8 with mono-substituted piperazines, or by the formation of piperazine 9 or indole 10 rings. The most attractive way for the preparation of 4-(1H-indol-3-yl)butyl]piperazine derivatives is the modification of commercially available 4-(1H-indol-3-yl)butanoic acid (1).
11,12
Results and Discussion
It is well known from the literature that mono-acylpiperazines can be easily synthesized from the corresponding acids and excess of piperazine using N-bromosuccinimide and triphenylphosphine. This method allows the preparation of desired compounds under mild Unfortunately, the hydrolysis of compound 8a could not be accomplished selectively to compound 3. Both basic and acidic hydrolysis led to the formation of initial acid 1 or its methyl ester 9, and significant amount of tar-like side products. In contrast, the hydrolysis of t-butyl-4-[4-(1H-indol-3-yl)butanoyl]piperazine-1-carboxylate (8b) was accomplished successfully. The hydrolysis using catalytic amount of hydrochloric acid in methanol resulted quantitative yield of target 3-(4-oxo-4-piperazin-1-ylbutyl)-1H-indole (3) in milligram scale. The same reaction carried out in multi-gram scale yielded 50% of target compound 3. Significant amount of the starting 4-(1H-indol-3-yl)butanoic acid (1) was isolated too. It seems that t-butyl-4-[4-(1H-indol-3-yl)butanoyl]piperazine-1-carboxylate, even being more reactive under examined hydrolysis conditions than ethyl-4-[4-(1H-indol-3-yl)butanoyl]piperazine-1-carboxylate, is not reactive enough and hydrolysis of these compounds is not very consistent.
The reduction of compound 3 using lithium aluminum hydride yielded only 52% of expected 3-[4-(1-piperazinyl)butyl]-1H-indole 2. An addition of equimolar amount of aluminum chloride improved the yield of compound 2 up to 67%.
Since the overall yield of product 2 starting from 4-(1H-indol-3-yl)butanoic acid (1) was unsatisfying (20%) and the hydrolysis step was inconsistent, we decided to search for more efficient method for synthesis of the compound 2. An alternative route involving modification of 4-(1H-indol-3-yl)butan-1-ol 1 (10) was employed. The starting alcohol was synthesized by esterification of 4-(1H-indol-3-yl)butanoic acid (1) to methyl 4-(1H-indol-3-yl)butanoate (9) , which was subsequently reduced with lithium aluminum hydride (Scheme 2). Alcohol 10 was tosylated in ethyl acetate using pyridine as a base and the resulting product 11 was used for alkylation of N-protected piperazines. Surprisingly, the yield of tert-butyl 4-[4-(1H-indol-3-yl)butyl]piperazine-1-carboxylate (12b) was very low (11%), while ethyl 4-[4-(1H-indol-3-yl)butyl]piperazine-1-carboxylate (12a) was isolated in good yield (69%). Both of compounds 12a and 12b were successfully hydrolyzed to piperazine derivative 2 in high yields. This alternative method allows to synthesize target 3-[4-(1-piperazinyl)butyl]-1H-indole (2) in overall 52% yield.
Further alkylation or arylation of 4-(1H-indol-3-yl)butyl]piperazine (2) with various alkyl halides was carried out in acetonitrile in the presence of base (DIPEA or potassium carbonate) and gave desired products 13a-i in high yields (Scheme 3). In contrast, arylation with various pyridine or pyrimidine halides was inconsistent, target products have not formed or formed in very low yields even when copper or palladium catalysis was applied. Esters 9 and 13a-c were treated with hydroxylamine hydrochloride at room temperature and converted to corresponding hydroxamic acids 14a-c and 15 (Scheme 4) in a moderate to good yields.
Conclusions
We have investigated two synthetic routes for synthesis of 4-(1H-indol-3-yl)butyl]piperazine starting form 4-(1H-indol-3-yl)butanoic acid. In multi-gram scale five step synthesis through intermediate 4-(1H-indol-3-yl)butan-1-ol (total yield 52%) was twice as efficient as four step synthesis through intermediate 3-(4-oxo-4-piperazin-1-ylbutyl)-1H-indole (total yield 20%). We have synthesized several alkylated and arylated derivatives of 4-(1H-indol-3-yl)butyl]piperazine and tested their antiproliferative activity in vitro.
Experimental Section
General. Melting points were determined in open capillaries and are uncorrected. NMR spectra were recorded on Varian Unity Inova (300 MHz for 1 H NMR and 75 MHz for 13 C NMR) using residual solvent peaks as internal standards. The purity of compounds was monitored by TLC using silica gel 60 F254 aluminum plates (Merck). Column chromatography was carried out using silica gel 60 (0.04 -0.063 mm) (Roth).
General procedure for the synthesis of compounds 8a and 8b. Ethyl 4-[4-(1H-indol-3-yl)butanoyl]-1-piperazinecarboxylate (8a). To the stirred solution of 4-(1H-indol-3-yl)butanoic acid (1 g, 4.9 mmol) and trimethylamine (0.5 g, 4.9 mmol) in 10 mL of THF, ethyl chlorocarbonate (0.54 g, 4.9 mmol) solution in 10 mL of THF was added dropwise at 0-3 ºC. After the formation of white precipitate the reaction mixture was stirred at 0-3 ºC for 1 h. Then the precipitate (triethylamine hydrochloride) was filtered off and washed with 10 mL of THF. Filtrate was used in the next step without isolation of the intermediate product. Filtrate was added dropwise to a solution of ethyl piperazine-1-carboxylate (1.2 g, 7.35 mmol) in 10 mL of THF at 0-3 ºC and the resulting mixture was stirred at room temperature overnight. The precipitate was filtered off, washed with 5 mL of THF and the mother liquid was concentrated under the reduced pressure. The solid residue was dissolved in 5 mL of dichloromethane and washed twice with 5 mL of saturated sodium carbonate aqueous solution, and with 5 mL of water. Organic phase were dried with anhydrous Na 2 SO 4 and solvent was evaporated under reduced pressure. Product was purified by recrystallization from toluene/hexane mixture yielding 1.1 g (65%) of pure product 8a. 
tert-Butyl 4-[4-(1H-indol-3-yl)butanoyl]-1-piperazinecarboxylate (8b). tert-Butyl
4-[4-(1H- indol-3-yl)butanoyl]-1
3-[4-Oxo-4-(1-piperazinyl)butyl]-1H-indole (3).
To a solution of compound 8b (1.1 g, 3 mmol) in 15 mL of methanol, 1 mL of conc. HCl was added and the solution was stirred under reflux temperature for 1.5 h. Reaction mixture was cooled down and after the addition of 5 mL of water neutralized with saturated sodium carbonate solution. The product was extracted with DCM (2 × 5 mL). Organic phases were combined, washed with water (2 × 5 mL), dried with anhydrous Na 2 SO 4 , and concentrated under reduced pressure. Product was purified by column chromatography eluting with methanol/ammonium hydroxide mixture. Yield 0.4 g (50%) of pure product 3. 
3-[4-(1-Piperazinyl)butyl]-1H-indole (2)
Method A Reduction of 3-(4-oxo-4-piperazin-1-ylbutyl)-1H-indole (3) without AlCl 3 . To a stirred suspension of LiAlH 4 (0.1 g, 2.7 mmol) in dry THF (5 mL) the solution of compound 3 (0.4 g, 1.5 mmol) in dry THF (10 mL) was added dropwise. The resulted mixture was stirred under reflux temperature for 10 h. Reaction mixture was cooled down to room temperature, quenched with acetone (5 mL) and ice cold 10% aqueous solution of KOH (20 mL). Precipitate was filtered off, washed with THF and filtrate was concentrated under reduced pressure. Resulting solid residue was partitioned between dichloromethane and water (3 mL : 2 mL). Organic phase washed with water (2×2 mL) dried with anhydrous Na 2 SO 4 and concentrated under reduced pressure. Product 2 was purified by column chromatography (eluted with ethyl acetate) yielding 0.2 g (52%) of pure product. White crystals, mp 143-144 °C. 1 mmol) in dry THF (50 mL) was added dropwise keeping the reaction mixture temperature below 3 °C. Reaction mixture was stirred for 30 min, quenched with 2 mL of water and 4 mL of 25% solution of NaOH in water, and stirred for additional 2 h. Formed precipitate was filtered off, washed with THF and filtrate was concentrated under reduced pressure. Product was purified in the same way as described above. Yield 1.4 g (67%) of title compound.
Method C. Hydrolysis of tert-butyl 4-[4-(1H-indol-3-yl)butyl]-1-piperazinecarboxylate (12b).
The solution of tert-butyl 4-[4-(1H-indol-3-yl)butyl]-1-piperazinecarboxylate (12b) (1.3 g, 3.6 mmol) and conc. HCl (1 mL) was refluxed in 5 mL of methanol for 2 h. After the addition of water (50 mL) the resulted solution was basified with sodium carbonate solution to pH 8-9 and the product extracted with DCM (3×10 mL). Organic phases were combined, washed with water (2×5 mL), dried over anhydrous Na 2 SO 4 and evaporated under reduced pressure yielding 1 g (99%) of pure product 2. in ethanol (850 mL) the 50% aqueous solution of NaOH (880 g, 22 mol of NaOH) was added and the resulting mixture was refluxed with stirring for 4 h. Ethanol was evaporated under reduced pressure, resulting residue was extracted with DCM (3×150 mL), organic phase washed with water (3×100 mL), dried over anhydrous Na 2 SO 4 and evaporated under reduced pressure to give 59 g (93%) of pure product 2. 1H-indol-3-yl)butanoate (9) . The solution of 4-(1H-indol-3-yl)butanoic acid (1) (90 g, 0.443 mol) and 10 mL of conc. HCl in 1L of methanol was refluxed for 3 h. Methanol was evaporated under reduced pressure and the resulting solid was purified by recrystallization from 2-propanol, yielding 86 g (89%) of pure product 7. mp 58-60 ºC. (mp 59-60 ºC). 
Methyl 4-(
4-(1H-Indol-3-yl)butan-1-ol (10).
LiAlH 4 (18 g, 0.473 mol) was added in small portions to 750 mL of dry THF, then the solution of methyl 4-(1H-indol-3-yl)butanoate (9) (86 g, 0.394 mol) in 750 mL of THF was added to the reaction mixture dropwise (reaction is exotermic) and the resulting mixture was stirred at reflux temperature for 10 min. After cooling the reaction mixture to 15 ºC, an excess of lithium aluminum hydride was carefully quenched with acetone (approximately 300 mL, until gel is destroyed and small grey particles are formed) and 10% KOH ice cold solution in water (approximately 250 mL, until precipitate becomes white). The precipitated white solid was filtered off, washed with THF, the mother liquid was concentrated under reduced pressure. The resulted residue was dried by coevaporation twice with DCM and twice with toluene yielding 74 g (99%) of compound 10. Product was used in the next step without additional purification. 
4-(1H-Indol-3-yl)butyl 4-methylbenzenesulfonate (11).
To a stirred solution of compound 10 (74 g, 0.391 mol) and pyridine (60 mL, 0.78 mol) in 1000 mL of ethyl acetate, toluenesulfonyl chloride (112 g, 0.587 mol) was added and the resulting mixture was stirred at room temperature for 4 days. Then the solution was subsequently washed with 2 x 300 mL of water, 2 x 200 mL of 20% H 2 SO 4 aq. and with 2 x 200 mL of saturated NaHCO 3 solution. Organic layer was dried with anhydrous Na 2 SO 4 and concentrated under reduced pressure. White crystals were washed twice with 200 mL of hot hexane yielding 125 g (91%) of pure compound 11. mp 64-66 ºC (mp 65-66 ºC). 18 compounds 12a and 12b. tert-Butyl 4-[4-(1H-indol-3-yl)butyl]-1-piperazinecarboxylate (12b) . A mixture of compound 11 (7.5 g, 21.9 mmol), tertbutyl piperazine-1-carboxylate (6.1 g, 32.8 mmol) and N,N-diisopropylethylamine (4.3 g, 32.8 mmol) in 2-propanol (50 mL) was refluxed for 10 h. After the cooling to room temperature, the solvent was evaporated under reduced pressure. Then residue was partitioned between DCM and water (30 mL : 50 mL), organic phase was dried over Na 2 SO 4 and evaporated in vacuum. General procedure for synthesis of compounds 13a-i. To a solution of compound 2 (0.1 g, 0.388 mmol) in 2 mL of acetonitrile 1.55 mmol of the corresponding base (DIPEA or K 2 CO 3 ) and 0.388 mmol of the corresponding halide were added. The resulting reaction mixture was stirred at reflux temperature for the indicated period of time. After the completion of the reaction, the mixture was cooled to the room temperature, and concentrated under reduced pressure. The resulting residue was dissolved in 2 mL of DCM and 3 mL of water mixture, Indol-3-ylbutyl)piperazin-1-yl]methyl}imidazo[1,2-a]pyridine (13f) Indol-3-ylbutyl)piperazin-1-yl]-N-methylpyridine-3-carboxamide (13i) . Base: DIPEA, halide R-X: 2-Chloro-N-methylnicotinamide (i), reaction duration 30 h. Title compound with ethyl acetate -methanol mixture (92:8). Resulting oil recrystallized from toluene. White
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